Sweden’s first major international cannabis event “Cannabis in Focus” has now been cancelled by the organiser Aureum Life. Cancellation is due to the ongoing and […]
Auresacculin will be ready for the Swedish market within 18 months. Pharma company Aureum Life expects the research and development work to be finished in 6–8 months.
Aureum Life is launching its website today. Among other things, it presents the company’s ambitious plans for medical cannabis on the Swedish market, along with several upcoming facilities.